awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48401064-E1517273-488A-4021-A83E-460542308865
Q48401064-E1517273-488A-4021-A83E-460542308865
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-E1517273-488A-4021-A83E-460542308865
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
P50
Q48401064-E1517273-488A-4021-A83E-460542308865
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48401064-E1517273-488A-4021-A83E-460542308865
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa31f329697b8bc6ac8abcdb69efff22a6683840
P1545
6
http://www.w3.org/2001/XMLSchema#string
P50
Mario Santinami